Novo Nordisk Stock (NYSE:NVO), Quotes and News Summary

Q: What sector and industry does Novo Nordisk (NVO) operate in?

Novo Nordisk is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.

Novo Nordisk Stock (NYSE: NVO) stock price, news, charts, stock research, profile.

Open	$142.210
Close	-
Volume / Avg.	723.413K / 3.849M
Day Range	141.890 - 142.740
52 Wk Range	75.560 - 144.500
Market Cap	$633.085B
P/E Ratio	49.706
Dividend Yield	0.960%
Exchange	NYSE
RSI	65
Short Interest	0.26%
Days to Cover	1.45

Recent News

JPMorgan's $500M Venture Capital Fund Bets Big On Weight-Loss Drugs: 'They're All The Rage'

JPMorgan's $500M venture capital fund dives into weight-loss craze, eyeing potential market upheaval in pharmaceuticals.

Nabaparna Bhattacharya

Ozempic Maker Novo Nordisk Closes In On Lego As Denmark's Most Valuable Brand: Report

Novo Nordisk is challenging Lego A/S for the title of Denmark's most valuable brand, with its brand value surging 59% to $5.1 billion. This growth is fueled by the global popularity of its weight-loss drugs, Ozempic and Wegovy.

Shivani Kumaresan

Humans Clamor For Weight Loss Drugs, But The Next Users Could Be... Pets?

Could GLP-1 drugs for weight loss in pets be the next big thing? Success of Novo Nordisk and Eli Lilly in human market could pave the way.

Hayden Buckfire

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Jan

Feb

Mar

Apr

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Novo Nordisk (NVO) stock?

You can purchase shares of Novo Nordisk (NYSE:NVO) through any online brokerage.

View our list of the best stock brokerages

Who are Novo Nordisk (NVO) competitors?

Other companies in Novo Nordisk’s space includes: Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS), Pfizer (NYSE:PFE) and Axsome Therapeutics (NASDAQ:AXSM).

What is the target price for Novo Nordisk (NVO) stock?

There is no analysis for Novo Nordisk

Current stock price for Novo Nordisk (NVO)?

The stock price for Novo Nordisk (NYSE: NVO) is $142.125 last updated Today at June 14, 2024 at 10:51 AM EDT.

Does Novo Nordisk (NVO) pay a dividend

A quarterly cash dividend of 2.50 per share of Class A Common Stock. The quarterly cash dividend was payable on April 2, 2012 to stockholders of record on March 22, 2012.

When is Novo Nordisk (NYSE:NVO) reporting earnings?

Novo Nordisk’s Q2 earnings are confirmed for Thursday, August 8, 2024.

Is Novo Nordisk (NVO) going to split?

There is no upcoming split for Novo Nordisk.

What sector and industry does Novo Nordisk (NVO) operate in?

Novo Nordisk is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.

-

-

-

-

-

-

-

-

-

-

-

-

-

-